| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |